Mesothelioma is a particularly challenging form of cancer that has proven extremely resistant to traditional treatment protocols. Most patients are offered multimodality treatments that include chemotherapy, and that regimen can lead to a troubling side effect referred to as ‘chemobrain.’ This week researchers have published a study that suggests that it may be caused by
Dr. Jordan D. Miller is a thoracic surgeon and member of the Lung and Thoracic Cancer Team at the University of Kentucky’s UK Markey Cancer Center. He specializes in treating patients with lung cancer, esophageal cancer, pleural mesothelioma, and other conditions, using a variety of high-level techniques, including minimally invasive surgery and video-assisted thoracoscopic surgery.
Dr. Chao H. Huang is a medical oncologist and hematologist at the University of Kansas Medical Center and the University of Kansas Cancer Center. As director of the Lung Cancer Program, he leads a multidisciplinary team in diagnosing and staging patients’ lung cancer and other chest cancers before developing an individual, personalized treatment plan designed
Dr. Kalpaj R. Parekh is an experienced and accomplished cardiothoracic surgeon at the University of Iowa Hospitals and Clinics, as well as the Holden Comprehensive Cancer Center. While his primary interest is in lung transplantation, his clinical efforts and expertise include surgical care of lung cancer and esophageal cancer patients. His technical skills include lung transplant,
Dr. Muhammad Furqan is a medical oncologist and hematologist at the University of Oklahoma Health Stephenson Cancer Center. As a specialist in lung cancer treatment and research, he is a professor and associate section chief for Research in Solid Tumor Oncology. He has been practicing medicine for almost twenty years. Education and Career Dr. Furqan
Dr. Chad E. Denlinger is a thoracic surgeon at Indiana University Health in Indianapolis and a tenured Professor of Surgery at Indiana University School of Medicine. An expert in diseases of the chest, his clinical interests include the treatment of lung cancer and esophageal cancer, advanced lung disease, lung transplant, gastroesophageal reflux disease, cardiothoracic surgery,
Dr. Nasser H. Hanna is a medical oncologist focused on thoracic oncology in Indianapolis, Indiana. He is the Associate Division Director of the Department of Oncology, as well as the Tom and Julie Wood Family Foundation Professor of Lung Cancer Clinical Research and a Professor of Medicine in the Division of Hematology/Oncology at the Indiana
As a pulmonologist and critical care specialist, Dr. Francis D. Sheski is an invaluable member of Indiana University’s cancer treatment program and the Indiana University School of Medicine in Indianapolis, Indiana. His clinical interests include interventional pulmonology for lung cancer and pleural diseases, and he specializes in bronchoscopy and thoracoscopy. Education Dr. Sheski has an
Dr. Darren Bryan is a thoracic surgeon who has dedicated himself to caring for patients with lung cancer, pleural mesothelioma, and other thoracic conditions. He is a member of the University of Chicago Comprehensive Cancer Center’s mesothelioma treatment team, using his skills in both traditional and minimally invasive/robotic surgical techniques to provide the best outcomes for his
Dr. Mark Ferguson is a thoracic and cardiac surgeon at the University of Chicago Medicine. His surgical specialty is the management of lung, esophageal, and thymus diseases. He is experienced in all techniques of lung and esophageal resection, as well as the management of malignant pleural effusions. Education and Career Board-certified in thoracic surgery, Dr.